FIGURE 2 3 Clinical applications of GLP-1RAs: comprehensive protection through multi-disease risk reduction 3.1 Cardiovascular protection GLP-1RAs confer substantial cardiovascular benefits that extend beyond glycemic control, primarily by reducing the incidence of major adverse cardiovascular events (MACE)
Counterfeit clinics, counterfeit providers, and counterfeit GLP-1s are on the market in the U.S
Insights from Ozempic and Wegovy Users Insights from users of Ozempic and Wegovy, both formulations of semaglutide, have been featured prominently in discussions surrounding its effectiveness
Most patients report decreased hunger and earlier satiety within the first one to two weeks of starting GLP-1 therapy
Hurtado Andrade, MD, also suggested HRT might make it easier to shed pounds by improving sleep and other quality-of-life measures
They have been easy to work with and very responsive